Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families

British Journal of Cancer

Volumn 82, Issue 1, 2000, Pages 151-156

  Peelen, T ^a   Van Vliet, M ^a,e   Bosch, A ^a   Bignell, G ^c   Vasen, H F A ^b   Klijn, J G M ^d   Meijers Heijboer, H ^e   Stratton, M ^c   Van Ommen, G J B ^a   Cornelisse, C J ^b   Devilee, P ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

BRCA1; BRCA2; Breast cancer; Mutation analysis

Indexed keywords

BRCA2 PROTEIN; RESTRICTION ENDONUCLEASE;

ARTICLE; BREAST CANCER; EXON; FAMILIAL CANCER; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; HUMAN CELL; NETHERLANDS; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; RESTRICTION MAPPING; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

EID: 0033988223     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0892     Document Type: Article

References (25)

1. Cornelis R, Vasen H, Meijers-Heijboer H, Ford D, Van Vliet M, Van Tilborg A, Cleton F, Klijn J, Menko F, Meera Khan P, Cornelisse C and Devilee P (1995) Age at diagnosis as an indicator of eligibility for BRCA1 DNA-testing in familial breast cancer. Hum Genet 95: 539-544
2. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M and the Breast Cancer Linkage Consortium (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62: 676-689
3. Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BAJ, Stratton MR and Easton D (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15: 103-105
4. Hogervorst F, Cornelis R, Bout M, Van Vliet M, Oosterwijk J, Olmer R, Bakker B, Klijn J, Vasen H, Meijers-Heijboer H, Menko F, Cornelisse C, Den Dunnen J, Devilee P and Van Ommen G-J (1995) Rapid detection of BRCA1 mutations by the Protein Truncation Test. Nat Genet 10: 208-212
5. Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR and Futreal PA (1996) BRCA2 mutations in primary breast and ovarian cancers. Nature Genet 13: 238-240
6. Miki Y, Katagiri T, Kasumi F, Yoshimoto T and Nakamura Y (1996) Mutation analysis in the BRCA2 gene in primary breast cancers. Nature Genet 13: 245-247
7. Miller SA, Dykes DD and Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215-1215
8. Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D and Offit K (1996) Recurrent BRCA2 6174deIT mutations in Askenazi Jewish women affected by breast cancer. Nature Genet 13: 126-128
9. Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Scrova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, Scott RJ, Schofield A, Teugels E, Schwab M, Cannon-Albright L, Bishop T, Easton D, Benitez J, King MC, Ponder BA, Weber B, Devilee P, Borg A, Narod SA and Goldgar D (1998) Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet 62: 1381-1388
10. Nordling M, Karlsson P, Wahlstrom J, Engwall Y, Wallgren A and Martinsson T (1998) A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Cancer Res 58: 1372-1375
11. Peelen T, Cornelis RC, Van Vliet M, Petrij-Bosch A, Cleton-Jansen A-M, Meijers-Heijboer H, Klijn JGM, Vasen HFA, Cornelisse CJ and Devilee P (1996) The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2. Eur J Hum Genet 4: 225-230
12. Peelen T, Van Vliet M, Petrij-Bosch A, Micremet R, Szabo C, Van den Ouweland AMW, Hogervorst F, Brohet R, Ligtenberg MJL, Teugels E, Van der Luijt R, Van der Hout AH, Gille JJP, Pals G, Jedema I, Olmer R, Van Leeuwen I, Newman B, Plandsoen M, Van der Est M, Brink G, Hageman S, Arts PJW, Bakker MM, Willems HW, Van der Looij E, Neyns B, Bonduelle M, Jansen R, Oosterwijk JC, Sijmons R, Smeets HJM, Van Asperen CJ, Meijers-Heijboer H, Klijn JGM, De Greve J, King MC, Menko FH, Brunner HG, Halley D, Van Ommen G-JB, Vasen HFA, Cornelisse CJ, Van't Veer LJ, De Knijff P. Bakker E and Devilee P (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60: 1041-1049
13. Petrij-Bosch A, Peelen T, Van Vliet M, Van Eijk R, Olmer R, Drüsedau M, Hogervorst FBL, Hageman S, Arts PJW, Ligtenberg MJL, Meijers-Heijboer H, Klijn JGM, Vasen HFA, Cornelisse CJ, Van't Veer LJ, Bakker E, Van Ommen G-JB and Devilee P (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nature Genet 17: 341-345
14. Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher M-C, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA and Futreal PA (1996) Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nature Gener 13: 120-122
15. Puget N, Torchard D, Serova-Sinilnikova OM, Lynch HT, Feunteun J, Lenoir GM and Mazoyer S (1997) A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res 57: 828-831
16. Puget N, Sinilnikova OM, Stoppa-Lyonnet D, Audoynaud C, Pag, Lynch HT, Goldgar D, Lenoir GM und Mazoyer S (1999a) An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am J Hum Genet 64: 300-302
17. Puget N, Stoppalyonnet D, Sinilnikova OM, Pages S, Lynch HT, Lenoir GM and Mazoyer S (1999b) Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 59: 455-461
18. Rahman N and Stratton MR (1998) The genetics of breast cancer susceptibility. Annu Rev Genet 32: 95-121
19. Ramus SJ, Kotejarai Z, Friedman LS, Van der Looij M, Gayther SA, Csokay B, Ponder BA and Olah E (1997) Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Am J Hum Genet 60: 1242-1246
20. Serova-Sinilnikova OM, Boutrand L, Sloppa-Lyonnet D, Bressac-Depaillerets B, Dubois V, Lasset C, Janin N, Bignon YJ, Longy M, Maugard C, Lidereau R, Leroux D, Frebourg T, Mazoyer S and Lenoir GM (1997) BRCA 2 mutations in hereditary breast and ovarian cancer in France. Am J Hum Genet 60: 1236-1239
21. Smith TM, Lee MK, Szabo CI, Jerome N, Mceuen M, Taylor M, Hood L and King MC (1996) Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 6: 1029-1049
22. Szabo CI and King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60: 1013-1020
23. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ögmundsdottir HM and Eyfjörd JE (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature Genet 13: 117-119
24. Tonin PN, Mesmasson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DEC, Provencher D, Ghadirian P and Narod SA (1998) Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63: 1341-1351
25. Vehmanen P, Friedman LS, Ecrola H, Sarantaus L, Pyrhonen S, Ponder BAJ, Muhonen T and Nevanlinna H (1997) A low proportion of BRCA2 mutations in Finnish breast cancer families. Am J Hum Genet 60: 1050-1058